TLRY vs TRLV
Tilray Brands, Inc. and Trulieve Cannabis Corp., side by side — 7 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | TLRY | TRLV |
|---|---|---|
| Revenue | $915.5M | $1.2B |
| Net income | $-121.4M | $-122.2M |
| Gross margin | 28.4% | 60.2% |
| Net margin | −11.5% | −10.3% |
| Return on equity | −7.8% | −10.2% |
| Diluted EPS | −$1.09 | −$0.58 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | · | $228.6M |
| Equity | $1.6B | · |
| Net debt / equity | −0.13× | −0.10× |
| Current ratio | 2.21× | 4.43× |
| Revenue CAGR 5y | 12.3% | 17.8% |
| Profit CAGR 5y | · | · |
TRLV bills 1.3× the revenue of TLRY, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
7 years side by side
| Fiscal year | TLRY | TRLV |
|---|---|---|
| FY2025 | $915.5M | $1.2B |
| FY2024 | $821.3M | $1.2B |
| FY2023 | $788.9M | $1.1B |
| FY2022 | $627.1M | $1.2B |
| FY2021 | $628.4M | $931.9M |
| FY2020 | $513.1M | $521.5M |
| FY2019 | $405.3M | $252.8M |
Bottom line
| Fiscal year | TLRY | TRLV |
|---|---|---|
| FY2025 | $-121.4M | $-122.2M |
| FY2024 | $-2.2B | $-160.6M |
| FY2023 | $-245.0M | $-533.1M |
| FY2022 | $-1.5B | $-252.7M |
| FY2021 | $-476.8M | $17.4M |
| FY2020 | $-367.4M | $63.0M |
| FY2019 | $-102.5M | $53.1M |
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$265,726,000 | TRLV |
| FY2024 | −$365,181,000 | TRLV |
| FY2023 | −$340,251,000 | TRLV |
| FY2022 | −$591,105,000 | TRLV |
| FY2021 | −$303,562,000 | TRLV |
| FY2020 | −$8,448,000 | TRLV |
| FY2019 | +$152,507,000 | TLRY |
The higher-revenue side has changed between TLRY and TRLV over this period. The gap has widened since the earliest year compared.
7 of 10 comparable fiscal years — a year missing data on either side is not counted.
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −1.1 pp | TRLV |
| FY2024 | −252.1 pp | TRLV |
| FY2023 | +19.0 pp | TLRY |
| FY2022 | −209.4 pp | TRLV |
| FY2021 | −71.0 pp | TRLV |
| FY2020 | −77.6 pp | TRLV |
| FY2019 | −45.9 pp | TRLV |
The higher net margin has changed hands between TLRY and TRLV over this period.
7 of 10 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
TLRY's net margin has been more volatile than TRLV's over the 7 comparable fiscal years — 96.5 percentage points of standard deviation against 21.0.
7 of 10 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between TLRY and TRLV over these 7 fiscal years — TLRY led in 1 and TRLV in 6.
7 of 10 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
TLRY's return on equity has been more volatile than TRLV's over the 7 comparable fiscal years — 27.4 percentage points of standard deviation against 22.3.
7 of 8 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between TLRY and TRLV over these 7 fiscal years — TLRY led in 2 and TRLV in 5.
7 of 8 comparable fiscal years — a year missing data on either side is not counted.